Mechanism of Action DSIP's diverse effects likely result from its interaction with multiple receptor systems and signaling pathways
All medication decisionsincluding which alternative to consider, dosing, and monitoringshould be made by a qualified healthcare provider based on individual clinical evaluation
Medically, chromium enhances the action of insulin by improving the binding of insulin to its receptors and increasing the activity of downstream signaling pathways
Bridons research contributions include: Development of Drug Affinity Complex (DAC) technology for albumin binding and peptide half-life extension Identification and characterization of CJC-1295 as a long-lasting GRF analog with sustained growth hormone-releasing properties Pioneering work on maleimido-derivatized GHRH analogs and their bioconjugation to serum albumin Demonstration of 4-fold increase in growth hormone area-under-curve with optimized CJC-1295 formulation versus native GHRH Extensive in vitro and in vivo pharmacological characterization in rat and human models His 2005 publication in Endocrinology titled Human Growth Hormone-Releasing Factor (hGRF)1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog remains the foundational reference for CJC-1295 research, establishing the peptides mechanism of action and pharmacokinetic profile that enabled subsequent clinical investigation
Results: Average ~20-22% body weight loss (based on SURMOUNT trials)
The approach fails for someone needing to lose 50-100 pounds, where pharmaceutical intervention provides far superior results
)
